Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 37 Records) |
Query Trace: Leukemia and Mdm2[original query] |
---|
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia. Leukemia research 2010 Mar 34 (3): 335-9. Kaderi Mohd Arifin, Mansouri Mahmoud, Zainuddin Norafiza, Cahill Nicola, Gunnarsson Rebeqa, Jansson Mattias, Kimby Eva, Aleskog Anna, Lundin Jeanette, Glimelius Bengt, Melbye Mads, Juliusson Gunnar, Jurlander Jesper, Rosenquist Richa |
TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. Cancer genetics and cytogenetics 2009 Nov 195 (1): 31-6. Do Thuy N, Ucisik-Akkaya Esma, Davis Charronne F, Morrison Brittany A, Dorak M Tevf |
MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group. Pediatric blood & cancer 2010 Aug 55 (2): 248-53. Phillips Christine L, Gerbing Robert, Alonzo Todd, Perentesis John P, Harley Isaac T W, Meshinchi Soheil, Bhatla Deepika, Radloff Gretchen, Davies Stella |
MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia. European journal of haematology 2010 Sep 85 (3): 251-6. Willander Kerstin, Ungerbäck Jonas, Karlsson Karin, Fredrikson Mats, Söderkvist Peter, Linderholm Ma |
microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 2010 May 115 (21): 4191-7. Asslaber Daniela, Piñón Josefina D, Seyfried Irina, Desch Petra, Stöcher Markus, Tinhofer Inge, Egle Alexander, Merkel Olaf, Greil Richa |
MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL. International journal of cancer. Journal international du cancer 2012 May 130 (9): 2054-61. Dong Hua-Jie, Fang Cheng, Fan Lei, Zhu Dan-Xia, Wang Dong-Mei, Zhu Hua-Yuan, Zhuang Yun, Miao Kou-Rong, Liu Peng, Xu Wei, Li Jian-Yo |
A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia. Leukemia research 2011 Aug 35 (8): 1052-9. Iacobucci Ilaria, Sazzini Marco, Garagnani Paolo, Ferrari Anna, Boattini Alessio, Lonetti Annalisa, Papayannidis Cristina, Mantovani Vilma, Marasco Elena, Ottaviani Emanuela, Soverini Simona, Girelli Domenico, Luiselli Donata, Vignetti Marco, Baccarani Michele, Martinelli Giovan |
MDM2 SNP309 variation contributes to leukemia risk: meta-analyses based on 7259 subjects. Leukemia & lymphoma 2012 Nov 53 (11): 2245-52. Zhuo Wenlei, Zhang Liang, Ling Junjun, Zhu Bo, Chen Zhengta |
MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia. Asian Pacific journal of cancer prevention : APJCP 2012 13 (9): 9. Ebid GT, Sedhom IA, El-Gammal MM, Moneer MM |
Genetic variations in MDM2 and P53 genes confer risk for adult acute lymphoblastic leukemia in a Chinese population. DNA and cell biology 2013 Jul 32 (7): 414-9. Chen Jialu, Zhu Bo, Chen Jingwei, Li Yongji |
Clinical impact of SNP of P53 genes pathway on the adult AML patients. Hematology (Amsterdam, Netherlands) 2015 Jul 20 (6): 328-35. Abdel Hamid Thoraya M, El Gammal Mosaad M, Eibead Gamal T, Saber Mostafa M, Abol Elazm Omnia |
Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (16): 6767-72. Yan Yu-Lan, Han Feng, Tan Wen-Min, Wu Cui-Ping, Qin |
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis. Haematologica 2014 Aug 99 (8): 1285-91. Benner Axel, Mansouri Larry, Rossi Davide, Majid Aneela, Willander Kerstin, Parker Anton, Bond Gareth, Pavlova Sarka, Nückel Holger, Merkel Olaf, Ghia Paolo, Montserrat Emili, Kaderi Mohd Arifin, Rosenquist Richard, Gaidano Gianluca, Dyer Martin J S, Söderkvist Peter, Linderholm Mats, Oscier David, Tvaruzkova Zuzana, Pospisilova Sarka, Dührsen Ulrich, Greil Richard, Döhner Hartmut, Stilgenbauer Stephan, Zenz Thorsten, |
MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study. Annals of clinical and laboratory science 2014 44 (4): 449-54. El-Danasouri Nabil Mohsen, Ragab Shadia Hassan, Rasheed Maha Ameen, Ali El Saadany Zainab, Abd El-Fattah Safa Nab |
ESR1 rs9340799 is associated with endometriosis-related infertility and in vitro fertilization failure. Disease markers 2013 35 (6): 907-13. Paskulin Diego Davila, Cunha-Filho João Sabino, Paskulin Livia Davila, Souza Carlos Augusto Bastos, Ashton-Prolla Patric |
Role of the MDM2 promoter polymorphism (-309T>G) in acute myeloid leukemia development. Asian Pacific journal of cancer prevention : APJCP 2015 16 (7): 2707-12. Cingeetham Anuradha, Vuree Sugunakar, Jiwatani Sangeeta, Kagita Sailaja, Dunna Nageswara Rao, Meka Phanni Bhushann, Gorre Manjula, Annamaneni Sandhya, Digumarti Raghunadharao, Sinha Sudha, Satti Vishnupri |
Association of MDM2 polymorphism with risk and prognosis of leukemia: a meta-analysis. Acta haematologica 2015 133 (4): 365-71. He Xuepeng, Chen Peng, Yang Kai, Liu Bing, Zhang Yuan, Wang Fang, Guo Zhi, Liu Xiaodong, Lou Jinxing, Chen Huir |
Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia. Medical science monitor : international medical journal of experimental and clinical research 2015 21 213-8. Ou Wen-B |
The Relationship Between MDM2 T309G Polymorphism and Leukemia in the Chinese Population: Evidence from a Meta-Analysis. Clinical laboratory 2017 Oct 63 (10): 1639-1645. Zhao Dewan, Liu Ti |
Lack of UGT polymorphism association with idasanutlin pharmacokinetics in solid tumor patients. Cancer chemotherapy and pharmacology 2019 Jan 83 (1): 209-213. So W Venus, Ou Yang Tai-Hsien, Yang Xing, Zhi Jiang |
NOTCH1, SF3B1, MDM2 and MYD88 mutations in patients with chronic lymphocytic leukemia. Oncology letters 2019 Apr 17 (4): 4016-4023. Maleki Yosra, Alahbakhshi Zahra, Heidari Zahra, Moradi Mohammad-Taher, Rahimi Ziba, Yari Kheirolah, Rahimi Zohreh, Aznab Mozafar, Ahmadi-Khajevand Meisam, Bahremand Faribo |
Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations. American journal of hematology 2019 3 94 (6): 650-657. Leung Garret M K, Zhang Chunxiao, Ng Nelson K L, Yang Ning, Lam Stephen S Y, Au Chun H, Chan Tsun L, Ma Edmond S K, Tsui Sze P, Ip Ho W, So Jason C C, Ng Margaret H L, Cheng Kelvin C K, Wong Kit F, Siu Lisa L P, Yip Sze F, Lin Shek Y, Lau June S M, Luk Tsan H, Lee Harold K K, Lau Chi K, Kho Bonnie, Kwong Yok L, Leung Anskar Y |
Association of Mouse Double Minute 2 -309T>G Polymorphism with Acute Myeloid Leukemia in an Iranian Population: A Case- Control Study. Asian Pacific journal of cancer prevention : APJCP 2019 Oct 20 (10): 3037-3041. Soleymannejad Mona, Sheikhha Mohammad Hassan, Neamatzadeh Hosse |
Evaluation of TP53 Codon 72, P21 Codon 31, and MDM2 SNP309 Polymorphisms in Iranian Patients with Acute Lymphocytic Leukemia. Reports of biochemistry & molecular biology 2020 Apr 9 (1): 26-32. Lotfi Garavand Ahmad, Mohammadi Mohammad, Mohammadzadeh Sa |
Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study. Journal of clinical medicine 2020 6 9 (6): . Tripon Florin, Iancu Mihaela, Trifa Adrian, Crauciuc George Andrei, Boglis Alina, Balla Beata, Cosma Adriana, Dima Delia, Candea Marcela, Lazar Erzsebet, Jimbu Laura, Banescu Claud |
Phase 1 study of the MDM2 antagonist RO6839921 in patients with acute myeloid leukemia. Investigational new drugs 2020 2 38 (5): 1430-1441. Uy Geoffrey L, Assouline Sarit, Young Anne-Marie, Blotner Steven, Higgins Brian, Chen Lin-Chi, Yee Kar |
Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches. Current hematologic malignancy reports 2021 3 16 (2): 192-206. Grieselhuber Nicole R, Mims Alice |
p53 p.Pro72Arg (rs1042522) and Mouse Double Minute 2 (MDM2) Single-Nucleotide Polymorphism (SNP) 309 Variants and Their Interaction in Chronic Lymphocytic Leukemia(CLL): A Survey in CLL Patients from Western Iran. International journal of hematology-oncology and stem cell research 2022 1 15 (3): 160-169. Jalilian Nazanin, Maleki Yosra, Shakiba Ebrahim, Aznab Mozafar, Rahimi Ziba, Salimi Mehdi, Rhimi Zohr |
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants. Annals of hematology 2024 5 . María Belén Fontecha, María Del Rosario Anadón, Verónica Mercado Guzmán, Carmen Stanganelli, Camila Galvano, Fernanda Tosin, Javier Bordone, Raimundo Bezares, Cecilia Rodríguez, Viviana Heller, Irma Slavutsky, Ariela Freya Fund |
Exploring the significance of MDM2 gene promoter variants in chronic myeloid leukemia. Leukemia research 2025 1 149 107644. María Belén Fontecha, María Del Rosario Anadón, Inés María Martínez Lahitou, Natalia Weich, Raquel Bengió, Beatriz Moiraghi, Irene Larripa, Ariela Freya Fund |
- Page last reviewed:Feb 1, 2024
- Content source: